Alpha-1 Antitrypsin Deficiency with Emphysema

Medical Condition: Alpha-1 Antitrypsin Deficiency

Facility/Clinic: PMG Research of Wilmington

Age: 18-75

Gender: Male/Female


A research study is evaluating an investigational medication that may slow the progression of alpha-1 antitrypsin deficiency in patients with emphysema.

This research study may be an option if you:

·         Have a clinical diagnosis of alpha-1 antitrypsin deficiency

·         Have evidence of emphysema

·         Have been a non-smoker for at least 12 months

·         Have no history of moderate to severe liver fibrosis

Other criteria apply.  Please make sure to discuss with a member of our research staff to ensure this research study is a good fit for you.

Qualified participants will receive all study-related care and study medication at no cost.

Enrollment: Open

Patient Commitment Duration: Approximately 5 months

Number of visits in study: Approximately 9 clinic visits and 2 phone calls

Patient Compensation: Financial compensation may be provided for time and travel expenses

Apply for this study below:

The team at WH Research can guide interested clinical research participants through the process of enrolling in a trial.
Please call 910-799-5500 between the hours of 8am-5pm for general research questions.